Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1. A second...
Main Authors: | Bowerman, M, Becker, C, Yáñez-Muñoz, R, Ning, K, Wood, M, Gillingwater, T, Talbot, K, UK SMA Research Consortium |
---|---|
פורמט: | Journal article |
יצא לאור: |
Company of Biologists
2017
|
פריטים דומים
-
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
מאת: Bowerman, M, et al.
יצא לאור: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
מאת: Melissa Bowerman, et al.
יצא לאור: (2017-08-01) -
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
מאת: Winkelsas, AM, et al.
יצא לאור: (2021) -
Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
מאת: Audrey M. Winkelsas, et al.
יצא לאור: (2021-03-01) -
SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
מאת: Wishart, T, et al.
יצא לאור: (2010)